Author

Beibei Zhao

Amorfix (Canada)ORCID 0000-0002-4445-8967Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Beibei Zhao3 papers · Johns Hopkins University

Biology Disciplines

Click to filter author papers

Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Ebrima GibbsiD· 1 shared Ian R. MackenzieiD· 1 shared Johanne M Kaplan· 1 shared Juliane A. Coutts· 1 shared Neil R. CashmaniD· 1 shared Steven Samuel PlotkiniD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Ebrima GibbsORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Relationship between therapeutic activity and preferential targeting of toxic soluble aggregates by amyloid-beta-directed antibodies

Johanne M Kaplan, Ebrima Gibbs, Juliane A. Coutts, Beibei Zhao, Ian R. Mackenzie, Steven Samuel Plotkin, Neil R. Cashman

The paper examines how the binding selectivity of amyloid-beta antibodies to toxic oligomers correlates with therapeutic efficacy and reduced risk of adverse effects in Alzheimer's disease.

Alzheimer s & Dementia Translational Research & Clinical Interventions · Oct 1, 2025Peer-reviewedNeuroscience